Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Identification of four snoRNAs (SNORD16, SNORA73B, SCARNA4, and SNORD49B) as novel non-invasive biomarkers for diagnosis of breast cancer

Fig. 4

Plasma snoRNAs: SNORD16, SNORA73B, SCARNA4, and SNORD49B as biomarkers for early diagnosis of BC. (A) The differential expressions of plasma SNORD16, SNORA73B, SCARNA4, and SNORD49B were analyzed in early-stage BC patients compared with health donors. The AUCs of plasma SNORD16 (B), SNORA73B (C), SCARNA4 (D), and SNORD49B (E) were 0.7072, 0.7097, 0.6697, and 0.6491, respectively. (F) The diagnostic performance for their combination demonstrated an AUC of 0.7305. ****P < 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us